Montelukast Sodium

Montelukast Sodium
Product Description

Montelukast Sodium is an active pharmaceutical ingredient (API) widely recognized for its efficacy in the treatment and management of asthma and allergic rhinitis. Montelukast Sodium acts as a selective and competitive leukotriene receptor antagonist, inhibiting the cysteinyl leukotriene (CysLT1) receptor responsible for airway inflammation, bronchoconstriction, and mucus secretion. Montelukast Sodium blocks leukotriene activity and improves breathing, reduces symptoms of asthma, and prevents exercise-induced bronchospasm.

Chemox Pharma is a trusted  Montelukast Sodium API manufacturer in india with IP/EP/USP standards. Chemox Pharma deliver high-quality APIs with stringent compliance to international regulatory requirements. Our API products are relied upon by leading pharmaceutical companies, showcasing our strong global presence. All our facilities operate under regulatory authorities such as DCGI, WHO-GMP, and FDA, ensuring consistency, safety, and efficacy.

Chemox Pharma Pvt Ltd

  • Country/Region:
    India
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    50 - 99
Company types
CMO/CDMO
Drug delivery device Supplier/Manufacturer
Pharmaceutical company
Primary activities
API Producer
Intermediates Manufacturer
Specifications
  • CAS Registry Number
    151767-02-1
  • Details
    • Chemical Name: 1-(((R)-3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl)thiourea sodium salt
    • CAS Number: 151767-02-1
    • Molecular Formula: C35H35ClNNaO3S
    • Molecular Weight: 608.2 g/mol
    • Therapeutic Uses: Anti-Asthmatic, Anti-Allergic
    • Specifications: IP/EP/USP
    • Appearance: White to off-white powder
    • Storage: Room temperature (<25°C)
    • Class: Leukotriene receptor antagonist | Anti-asthmatic agent

  • Selling Points
    Anti-Allergens

Chemox Pharma Pvt Ltd

  • Country/Region:
    India
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    50 - 99
Company types
CMO/CDMO
Drug delivery device Supplier/Manufacturer
Pharmaceutical company
Primary activities
API Producer
Intermediates Manufacturer

More Products from Chemox Pharma Pvt Ltd (14)

  • Benfotiamine

    Product Benfotiamine

    Benfotiamine [CAS No: 22457-89-2], also known as S-benzoylthiamine O-monophosphate, is a highly bioavailable lipid-soluble derivative of Vitamin B1 (Thiamine). As an advanced thiamine analogue, Benfotiamine plays an essential role in maintaining healthy nerve cell metabolism and supporting normal cellular ...
  • CITICOLINE SODIUM

    Product CITICOLINE SODIUM

    Citicoline Sodium [Cas No: 33818-15-4], is also known as CDP- Choline Sodium Salt, which is a main intermediate in the synthesis of phosphatidylcholine. Citicoline Sodium also plays a key role in maintaining brain cell membrane integrity and supports neurotransmitter synthesis. The use of Citicoline Sodium...
  • Deferoxamine Mesylate

    Product Deferoxamine Mesylate

    Deferoxamine Mesylate is an iron-chelating agent used to treat acute iron poisoning and chronic iron overload disorders. It works by binding excess iron in the bloodstream and tissues to form a stable complex called ferrioxamine, which is eliminated from the body through urine and bile. The ...
  • DORZOLAMIDE

    Product DORZOLAMIDE

    Dorzolamide Hydrochloride [Cas No. 130693-82-2] is a carbonic anhydrase inhibitor API widely used for treatment of glaucoma and ocular hypertension. Dorzolamide Hydrochloride inhibits carbonic anhydrase in the ciliary body by which it reduces aqueous humor production and lowers intraocular pressure [IOP]. ...
  • FLUCONAZOLE

    Product FLUCONAZOLE

    Fluconazole [Cas No. 86386-73-4] is a triazole antifungal API which is widely used for topical and systemic antifungal therapies. Fluconazole is first generation compound that targets a broad spectrum of fungus by inhibiting 14α-demethylase enzyme, which is a key component for ergosterol synthesis. Leading...
  • Iguratimod

    Product Iguratimod

    Iguratimod is a synthetic small-molecule conventional disease-modifying antirheumatic drug (csDMARD) with immunomodulatory and anti-inflammatory properties. It has been developed primarily for the treatment of rheumatoid arthritis (RA) and is used clinically in Japan and China.

    Iguratimod acts o...
  • NITROFURANTOIN

    Product NITROFURANTOIN

    Nitrofurantoin [Cas No. 67-20-9] is an antibacterial API which is effectively used for the treatment and prevention of urinary tract infections [UTIs]. Common market brand name for Nitrofurantoin is Macrobid, which breaks bacterial enzyme systems and DNA, resulting in inhibiting bacterial growth. Nitrofura...
  • Relugolix

    Product Relugolix

    Relugolix is a nonpeptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist. It acts directly on GnRH receptors in the pituitary gland, reducing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which subsequently decreases sex hormone production.
    ...
  • Rosuvastatin Calcium

    Product Rosuvastatin Calcium

    Rosuvastatin Calcium [CAS No: 147098-20-2] is used to manage dyslipidemia and prevent cardiovascular diseases. Rosuvastatin Calcium is widely used to reduce elevated levels of LDL cholesterol, total cholesterol and triglycerides, and moderately increase HDL cholesterol. Rosuvastatin Calcium is a HMG-CoA re...
  • Silodosin

    Product Silodosin

    Silodosin is a selective alpha-1 adrenergic receptor antagonist primarily targeting the α1A receptor subtype. It is used to improve urinary symptoms associated with benign prostatic hyperplasia (BPH) by relaxing smooth muscle in the prostate and lower urinary tract.

    Silodosin has a high affinity...
  • Tadalafil

    Product Tadalafil

    Tadalafil Citrate [Cas No. 171596-29-5] is a pharma grade phosphodiesterase type 5 [PDE5] inhibitor API which has potency in treating erectile dysfunction [ED] and pulmonary arterial hypertension [PAH]. Tadalafil Citrate has pyrazinopyridoindole and benzodioxol derivative that enhances nitric acid [NO] med...
  • Tigecycline

    Product Tigecycline

    Tigecycline [Cas No. 220620-09-7] is a glycylcycline antibiotic API which is structurally derived from tetracycline class and exhibits high potency, resistance and is very effective against gram positive and gram-negative bacteria. Tigecycline has broad antimicrobial spectrum and has potency to bypass trad...